unknown
Stage
1
Investors
About
CanCertain uses advanced 3D cell culture technology to identify the most effective personalized cancer treatment plans with a turnaround time of eight working days, aiming to improve treatment efficacy and patient quality of life.
Explore CanCertain's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.